Followers | 17 |
Posts | 1952 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
![](https://investorshub.advfn.com/uicon/760444.png?cb=1664148451)
Monday, July 05, 2021 1:55:00 AM
I don't know how to address your other concerns. I suspect any Tollivid/Tolliver income with be later on, not this early. Mobile test trailers seemed like an area to explore but probably didn't work out as expected. I would be surprised if we see any income from those sources.
Anyone who knows anything about business knows things never go as planned or expected. Some things may work out, others will not. Expectations of revenue in one area and then no revenue produced doesn't mean the company is lying. Even with a company as successful as Apple, I can give you a dozen or more examples of products or ventures that failed for them. It will be the same with Todos. Mobile labs may not pan out, where other ventures might. Lots of risk still, which is one reason the share price is where it is.
Yeah, JP is the one to follow. Look at the track record with AMBS, all over the map with that one, depending on which side of the flip he was on.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM